sb 200646 has been researched along with homovanillic acid in 1 studies
| Studies (sb 200646) | Trials (sb 200646) | Recent Studies (post-2010) (sb 200646) | Studies (homovanillic acid) | Trials (homovanillic acid) | Recent Studies (post-2010) (homovanillic acid) |
|---|---|---|---|---|---|
| 24 | 0 | 5 | 6,127 | 312 | 438 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klodt, PM; Kudrin, VS; Narkevich, VB; Rayevsky, KS | 1 |
1 other study(ies) available for sb 200646 and homovanillic acid
| Article | Year |
|---|---|
Effect of combined administration of afobazole and 5-HT2b/2c receptor antagonist SB-200646A on neurochemical profile of brain structures in C57Bl/6 and BALB/c mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Benzimidazoles; Biogenic Monoamines; Brain; Chromatography, High Pressure Liquid; Dopamine; Drug Combinations; Homovanillic Acid; Indoles; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Morpholines; Serotonin 5-HT2 Receptor Agonists; Urea | 2012 |